430 related articles for article (PubMed ID: 15557634)
1. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides.
Campos MA; Vargas MA; Regueiro V; Llompart CM; Albertí S; Bengoechea JA
Infect Immun; 2004 Dec; 72(12):7107-14. PubMed ID: 15557634
[TBL] [Abstract][Full Text] [Related]
2. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides.
Llobet E; Tomás JM; Bengoechea JA
Microbiology (Reading); 2008 Dec; 154(Pt 12):3877-3886. PubMed ID: 19047754
[TBL] [Abstract][Full Text] [Related]
3. The Neisseria meningitidis capsule is important for intracellular survival in human cells.
Spinosa MR; Progida C; Talà A; Cogli L; Alifano P; Bucci C
Infect Immun; 2007 Jul; 75(7):3594-603. PubMed ID: 17470547
[TBL] [Abstract][Full Text] [Related]
4. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides.
McCoy AJ; Liu H; Falla TJ; Gunn JS
Antimicrob Agents Chemother; 2001 Jul; 45(7):2030-7. PubMed ID: 11408219
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors.
Llobet E; Campos MA; Giménez P; Moranta D; Bengoechea JA
Infect Immun; 2011 Sep; 79(9):3718-32. PubMed ID: 21708987
[TBL] [Abstract][Full Text] [Related]
6. Release of the lipopolysaccharide deacylase PagL from latency compensates for a lack of lipopolysaccharide aminoarabinose modification-dependent resistance to the antimicrobial peptide polymyxin B in Salmonella enterica.
Kawasaki K; China K; Nishijima M
J Bacteriol; 2007 Jul; 189(13):4911-9. PubMed ID: 17483225
[TBL] [Abstract][Full Text] [Related]
7. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.
Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D
J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285
[TBL] [Abstract][Full Text] [Related]
8. Extended spectrum beta-lactamase-producing Klebsiella pneumoniae chronic ambulatory peritoneal dialysis peritonitis treated successfully with polymyxin B.
Parchuri S; Mohan S; Cunha BA
Heart Lung; 2005; 34(5):360-3. PubMed ID: 16157192
[TBL] [Abstract][Full Text] [Related]
9. Defining principles that influence antimicrobial peptide activity against capsulated
Fleeman RM; Macias LA; Brodbelt JS; Davies BW
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27620-27626. PubMed ID: 33087568
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity-specific to Gram-negative bacteria and immune modulation-mediated NF-kappaB and Sp1 of a medaka beta-defensin.
Zhao JG; Zhou L; Jin JY; Zhao Z; Lan J; Zhang YB; Zhang QY; Gui JF
Dev Comp Immunol; 2009 Apr; 33(4):624-37. PubMed ID: 19084554
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of RpoN-controlled genes protects Salmonella cells from killing by the cationic antimicrobial peptide polymyxin B.
Barchiesi J; Espariz M; Checa SK; Soncini FC
FEMS Microbiol Lett; 2009 Feb; 291(1):73-9. PubMed ID: 19076233
[TBL] [Abstract][Full Text] [Related]
12. Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells.
Moranta D; Regueiro V; March C; Llobet E; Margareto J; Larrarte E; Garmendia J; Bengoechea JA
Infect Immun; 2010 Mar; 78(3):1135-46. PubMed ID: 20008534
[TBL] [Abstract][Full Text] [Related]
13. PhoP-regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B.
Shi Y; Cromie MJ; Hsu FF; Turk J; Groisman EA
Mol Microbiol; 2004 Jul; 53(1):229-41. PubMed ID: 15225317
[TBL] [Abstract][Full Text] [Related]
14. Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides.
Gutsmann T; Hagge SO; David A; Roes S; Böhling A; Hammer MU; Seydel U
J Endotoxin Res; 2005; 11(3):167-73. PubMed ID: 15949145
[TBL] [Abstract][Full Text] [Related]
15. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides.
Rosenfeld Y; Sahl HG; Shai Y
Biochemistry; 2008 Jun; 47(24):6468-78. PubMed ID: 18498177
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
Alipour M; Halwani M; Omri A; Suntres ZE
Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants.
Wikraiphat C; Charoensap J; Utaisincharoen P; Wongratanacheewin S; Taweechaisupapong S; Woods DE; Bolscher JG; Sirisinha S
FEMS Immunol Med Microbiol; 2009 Aug; 56(3):253-9. PubMed ID: 19549172
[TBL] [Abstract][Full Text] [Related]
18. Roles of capsule and lipopolysaccharide O antigen in interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae.
Evrard B; Balestrino D; Dosgilbert A; Bouya-Gachancard JL; Charbonnel N; Forestier C; Tridon A
Infect Immun; 2010 Jan; 78(1):210-9. PubMed ID: 19841082
[TBL] [Abstract][Full Text] [Related]
19. A nanomechanical study of the effects of colistin on the Klebsiella pneumoniae AJ218 capsule.
Mularski A; Wilksch J; Hanssen E; Li J; Tomita T; Pidot SJ; Stinear T; Separovic F; Strugnell D
Eur Biophys J; 2017 May; 46(4):351-361. PubMed ID: 27752727
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of Yersinia enterocolitica temperature-dependent resistance to antimicrobial peptides.
Reinés M; Llobet E; Llompart CM; Moranta D; Pérez-Gutiérrez C; Bengoechea JA
J Bacteriol; 2012 Jun; 194(12):3173-88. PubMed ID: 22505678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
